Skip to main content
. 2020 Dec 18;13(12):dmm046375. doi: 10.1242/dmm.046375

Fig. 6.

Fig. 6.

merCremer activates the cell cycle in non-cardiomyocytes. (A-C) The effect of tamoxifen-activated merCremer on numbers of non-CMs exhibiting cell-cycle activation, as indicated by the nuclear presence of Ki67 (A), BrdU (B) and pH3 (C). (D) Typical examples of BrdU-positive nuclei in non-CMs (arrows). n=3 hearts per time point; *P<0.05 versus +/+.